Vaxart Enters Cooperation Agreement with Stockholder Group and Announces Board and Corporate Governance Enhancements

Vaxart resolved a proxy contest by entering a cooperation agreement with a stockholder group. The company will appoint a mutually agreed independent director within 90 days and form new board committees focused on stockholder engagement and clinical/regulatory affairs. The stockholder group withdrew its director nominations in exchange for enhanced corporate governance measures.